BiomX Inc. (NYSE AMERICAN: PHGE)
$0.5700
+0.0006 ( +0.60% ) 43.9K
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Market Data
Open
$0.5700
Previous close
$0.5694
Volume
43.9K
Market cap
$10.91M
Day range
$0.5680 - $0.6160
52 week range
$0.4800 - $8.5500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 1 | Jul 15, 2024 |
4 | Insider transactions | 2 | Jul 11, 2024 |
8-k | 8K-related | 16 | Jul 09, 2024 |
ars | Annual reports | 1 | Jun 17, 2024 |
def | Proxies and info statements | 24 | Jun 17, 2024 |
8-k/a | 8K-related | 18 | May 30, 2024 |
8-k | 8K-related | 14 | May 30, 2024 |